Xiaojia Wang
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Breast Cancer Treatment Studies
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 78
- HER2/EGFR in Cancer Research 44
- Cancer Treatment and Pharmacology 24
- Cancer-related Molecular Pathways 9
-
- Advanced Breast Cancer Therapies 37
- Co-authors
- Wen‐Ming Cao (21 shared papers)Xian Wang (8 shared papers)Zefei Jiang (21 shared papers)Hongchuan Jin (4 shared papers)Jifeng Feng (16 shared papers)Zhongsheng Tong (19 shared papers)Xiaoying Lin (2 shared papers)Yu‐An Huang (10 shared papers)
- Journals
- Journal of Clinical Oncology (20 papers)Cancer Research (9 papers)Frontiers in Oncology (4 papers)Cancer Medicine (4 papers)PLoS ONE (3 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Xiaojia Wang
141 papers receiving 2.8k citations
Xiaojia Wang's Hit Papers
Peers
Comparison fields: 5 of 129
- Cancer Research 604
- Oncology 770
- Behavioral Neuroscience 76
- Biological Psychiatry 35
- Molecular Biology 986
Countries citing papers authored by Xiaojia Wang
This map shows the geographic impact of Xiaojia Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojia Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojia Wang more than expected).
Fields of papers citing papers by Xiaojia Wang
This network shows the impact of papers produced by Xiaojia Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojia Wang. The network helps show where Xiaojia Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaojia Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 225 | |
| 2 | 2014 | 218 | |
| 3 | 2019 | 206 | |
| 4 | 2005 | 174 | |
| 5 | 2020 | 166 | |
| 6 | 2015 | 102 | |
| 7 | PI3K/AKT/mTOR signaling pathway: an important driver and therapeutic target in triple-negative breast cancer Hit paper breakdown → | 2024 | 88 |
| 8 | 2013 | 77 | |
| 9 | Klotho is silenced through promoter hypermethylation in gastric cancer. | 2010 | 77 |
| 10 | 2020 | 73 | |
| 11 | 2019 | 65 | |
| 12 | 2022 | 49 | |
| 13 | 2017 | 46 | |
| 14 | 2022 | 42 | |
| 15 | 2024 | 39 | |
| 16 | Growth inhibitory effect of Cucurbitacin E on breast cancer cells. | 2013 | 37 |
| 17 | 2017 | 35 | |
| 18 | 2023 | 33 | |
| 19 | 2013 | 32 | |
| 20 | 2022 | 30 |
About Xiaojia Wang
Xiaojia Wang is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research and Genetics, having authored 151 papers that have together received 2.8k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (44 papers), Advanced Breast Cancer Therapies (37 papers), Cancer Treatment and Pharmacology (24 papers), Breast Cancer Treatment Studies (17 papers), Monoclonal and Polyclonal Antibodies Research (12 papers), Cancer-related Molecular Pathways (9 papers), Estrogen and related hormone effects (8 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). The work is most often cited by research in Cancer Research (604 citations), Oncology (770 citations), Behavioral Neuroscience (76 citations), Biological Psychiatry (35 citations) and Molecular Biology (986 citations). Xiaojia Wang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Wen‐Ming Cao, Xian Wang, Zefei Jiang, Hongchuan Jin, Jifeng Feng, Zhongsheng Tong, Xiaoying Lin, Yu‐An Huang, Qingyuan Zhang and Yabing Zheng. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Frontiers in Oncology, Cancer Medicine and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.